In planta production of a candidate vaccine against bovine papillomavirus type 1

Planta

Volumn 236, Issue 4, 2012, Pages 1305-1313

  Love, Andrew J ^a   Chapman, Sean N ^a   Matic, Slavica ^b   Noris, Emanuela ^b   Lomonossoff, George P ^c   Taliansky, Michael ^a  

^a SCOTTISH CROP RESEARCH INSTITUTE   (United Kingdom)

^b INSTITUTE FOR SUSTAINABLE PLANT PROTECTION   (Italy)

^c JOHN INNES CENTRE   (United Kingdom)

Author keywords

Bovine papillomavirus; Codon optimization; Plant expression; Vaccine protein; Virus like particles

Indexed keywords

BOVINE PAPILLOMAVIRUS; BOVINE PAPILLOMAVIRUS TYPE 1; BOVINE PARVOVIRUS; EQUIDAE; NICOTIANA BENTHAMIANA; PAPILLOMAVIRIDAE;

EID: 84866909567     PISSN: 00320935     EISSN: 14322048     Source Type: Journal    
DOI: 10.1007/s00425-012-1692-0     Document Type: Article

References (44)

1. Ashrafi GH, Tsirimonaki E, Marchetti B, O'Brien PM, Sibbet GJ, Andrew L, Campo MS (2002) Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 21: 248-259.
2. Biemelt S, Sonnewald U, Gaimbacher P, Willmitzer L, Muller M (2003) Production of human papillomavirus type 16 virus-like particles in transgenic plants. J Virol 77: 9211-9220.
3. Bogaert L, Martens A, van Poucke M, Ducatelle R, De Cock H, Dewulf J, De Baere C, Peelman L, Gasthuys F (2008) High prevalence of bovine papillomaviral DNA in the normal skin of equine sarcoid-affected and healthy horses. Vet Microbiol 129: 58-68.
4. Borzacchiello G, Roperto F (2008) Bovine papillomaviruses, papillomas and cancer in cattle. Vet Res 39: 45.
5. Caciagli P, Piles VM, Marian D, Vecchiati M, Masenga V, Mason G, Falcioni T, Noris E (2009) Virion stability is important for the circulative transmission of tomato yellow leaf curl Sardinia virus by Bemisia tabaci, but virion access to salivary glands does not guarantee transmissibility. J Virol 83: 5784-5795.
6. Campo M (1995) Infection by bovine papillomavirus and prospects for vaccination. Trends Microbiol 3: 92-97.
7. Campo MS (2003) Vaccination against papillomavirus in cattle. Clin Dermatol 15: 275-283.
8. Canizares MC, Nicholson L, Lomonossoff GP (2005) Use of viral vectors for vaccine production in plants. Immunol Cell Biol 83: 263-270.
9. Fernandez-San Millan A, Ortigosa SM, Hervas-Stubbs S, Corral-Martinez P, Segui-Simarro JM, Gaetan J, Coursaget P, Veramendi J (2008) Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic. Plant Biotechnol J 6: 427-441.
10. Fischer R, Vaquero-Martin C, Sack M, Drossard J, Emans N, Commandeur U (1999) Towards molecular farming in the future: transient protein expression in plants. Biotechnol Appl Bioch 30: 113-116.
11. Fischer R, Stoger E, Schillberg S, Christou P, Twyman RM (2004) Plant-based production of biopharmaceuticals. Curr Opin Plant Biol 7: 152-158.
12. Foyer CH (2005) Redox homeostasis and antioxidant signaling: a metabolic interface between stress perception and physiological responses. Plant Cell 17: 1866-1875.
13. Giorgi C, Franconi R, Rybicki EP (2010) Human papillomavirus vaccines in plants. Expert Rev Vaccines 8: 913-924.
14. Jarrett WFH, Oneil BW, Gaukroger JM, Laird HM, Smith KT, Campo MS (1990) Studies on vaccination against papillomaviruses: a comparison of purified virus, tumor extract and transformed-cells in prophylactic vaccination. Vet Rec 126: 449-452.
15. Jarrett WFH, Smith KT, Oneil BW, Gaukroger JM, Chandrachud LM, Grindlay GJ, Mcgarvie GM, Campo MS (1991) Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins. Virology 184: 33-42.
16. Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT (1992) Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Nat Acad Sci USA 89: 12180-12184.
17. Kohl T, Hitzeroth II, Stewart D, Varsani A, Govan VA, Christensen ND, Williamson AL, Rybicki EP (2006) Plant-produced cottontail rabbit papillomavirus L1 protein protects against tumor challenge: a proof-of-concept study. Clin Vaccine Immunol 13: 845-853.
18. Kohl TO, Hitzeroth II, Christensen ND, Rybicki EP (2007) Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum. BMC Biotechnol 7: 56.
19. Kurg R, Uusen P, Sepp T, Sepp M, Abroi A, Ustav M (2009) Bovine papillomavirus type 1 E2 protein heterodimer is functional in papillomavirus DNA replication in vivo. Virology 386: 353-359.
20. Layne E (1957) Spectrophotometric and turbidimetric methods for measuring proteins. Method Enzymol 3: 447-454.
21. Lenzi P, Scotti N, Alagna F, Tornesello ML, Pompa A, Vitale A, De Stradis A, Monti L, Grillo S, Buonaguro FM, Maliga P, Cardi T (2008) Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco. Transgenic Res 17: 1091-1102.
22. Lindbo JA (2007) TRBO: a high-efficiency tobacco mosaic virus RNA-based overexpression vector. Plant Physiol 145: 1232-1240.
23. Liu XF, Schuck S, Stenlund A (2010) Structure-based mutational analysis of the bovine papillomavirus E1 helicase domain identifies residues involved in the nonspecific DNA binding activity required for double trimer formation. J Virol 84: 4264-4276.
24. Luisoni E, Milne RG, Vecchiati M (1995) Purification of tomato yellow leaf curl geminivirus. New Microbiol 18: 253-260.
25. Ma JKC, Barros E, Bock R, Christou P, Dale PJ, Dix PJ, Fischer R, Irwin J, Mahoney R, Pezzotti M, Schillberg S, Sparrow P, Stoger E, Twyman RM (2005) Molecular farming for new drugs and vaccines: current perspectives on the production of pharmaceuticals in transgenic plants. EMBO Rep 6: 593-599.
26. Maclean J, Koekemoer M, Olivier AJ, Stewart D, Hitzeroth II, Rademacher T, Fischer R, Williamson AL, Rybicki EP (2007) Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization. J Gen Virol 88: 1460-1469.
27. Matic S, Rinaldi R, Masenga V, Noris E (2011) Efficient production of chimeric Human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants. BMC Biotechnol 11: 106.
28. Matic S, Masenga V, Poli A, Rinaldi R, Milne RG, Vecchiati M, Noris E (2012) Comparative analysis of recombinant Human Papillomavirus 8 L1 production in plants by a variety of expression systems and purification methods. Plant Biotechnol J 10: 410-421.
29. Mohr IJ, Clark R, Sun S, Androphy EJ, Macpherson P, Botchan MR (1990) Targeting the E1 replication protein to the papillomavirus origin of replication by complex-formation with the E2 transactivator. Science 250: 1694-1699.
30. Nasir L, Campo MS (2008) Bovine papillomaviruses: their role in the aetiology of cutaneous tumours of bovids and equids. Vet Dermatol 19: 243-254.
31. Paintsil J, Muller M, Picken M, Gissmann L, Zhou JA (1998) Calcium is required in reassembly of bovine papillomavirus in vitro. J Gen Virol 79: 1133-1141.
32. Penney CA, Thomas DR, Deen SS, Walmsley AM (2011) Plant-made vaccines in support of the millennium development goals. Plant Cell Rep 30: 789-798.
33. Rybicki EP (2010) Plant-made vaccines for humans and animals. Plant Biotechnol J 8: 620-637.
34. Sainsbury F, Thuenemann EC, Lomonossoff GP (2009) pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants. Plant Biotechnol J 7: 682-693.
35. Shafti-Keramat S, Schellenbacher C, Handisurya A, Christensen N, Reininger B, Brandt S, Kirnbauer R (2009) Bovine papillomavirus type 1 (BPV1) and BPV2 are closely related serotypes. Virology 393: 1-6.
36. Strasser R, Castilho A, Stadlmann J, Kunert R, Quendler H, Gattinger P, Jez J, Rademacher T, Altmann F, Mach L, Steinkellner H (2009) Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta 1, 4-galactosylated N-glycan profile. J Biol Chem 284: 20479-20485.
37. Thones N, Muller M (2007) Oral immunization with different assembly forms of the HPV 16 major capsid protein L1 induces neutralizing antibodies and cytotoxic T-lymphocytes. Virology 369: 375-388.
38. Tong X, Salgia R, Li JL, Griffin JD, Howley PM (1997) The bovine papillomavirus E6 protein binds to the LD motif repeats of paxillin and blocks its interaction with vinculin and the focal adhesion kinase. J Biol Chem 272: 33373-33376.
39. Varsani A, Williamson AL, Rose RC, Jaffer M, Rybicki EP (2003) Expression of human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi. Arch Virol 148: 1771-1786.
40. Waheed MT, Thones N, Muller M, Hassan SW, Razavi NM, Lossl E, Kaul HP, Lossl AG (2011) Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: a step towards cost-effective second-generation vaccines. Transgenic Res 20: 271-282.
41. Wolf M, Garcea RL, Grigorieff N, Harrison SC (2010) Subunit interactions in bovine papillomavirus. Proc Nat Acad Sci USA 107: 6298-6303.
42. Zago M, Campo MS, O'Brien V (2004) Cyclin A expression and growth in suspension can be uncoupled from p27 deregulation and extracellular signal-regulated kinase activity in cells transformed by bovine papillomavirus type 4 E5. J Gen Virol 85: 3585-3595.
43. Zhao Q, Modis Y, High K, Towne V, Meng Y, Wang Y, Alexandroff J, Brown M, Carragher B, Potter CS, Abraham D, Wohlpart D, Kosinski M, Washabaugh MW, Sitrin RD (2012) Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity. Virol J 9: 52.
44. Zimmermann H, Koh CH, Degenkolbe R, O'Connor MJ, Muller A, Steger G, Chen JJ, Lui Y, Androphy E, Bernard HU (2000) Interaction with CBP/p300 enables the bovine papillomavirus type 1 E6 oncoprotein to downregulate CBP/p300-mediated transactivation by p53. J Gen Virol 81: 2617-2623.